Sheng Ding, PhD

1500 Owens St., Rm 274
San Francisco, CA 94158
United States

Joint appointments

What I do

My research focuses on discovering and characterizing novel small molecules that can control stem cell maintenance, activation, differentiation, and reprogramming in various tissue types.

My research expertise

Stem cell biology, Chemical biology, Drug discovery, Medicinal chemistry, High-throughput screening (HTS)

Degree

PhD, Chemistry, The Scripps Research Institute, 2003
Bachelors in Arts and Sciences, Chemistry, California Institute of Technology (Caltech), 1999

Biography

Dr. Sheng Ding is currently William K. Bowes, Jr. Distinguished Investigator and Professor at Gladstone Institute of Cardiovascular Disease, and Department of Pharmaceutical Chemistry, University of California San Francisco. He obtained his B.S. in chemistry with honors from Caltech in 1999, and a Ph.D. in chemistry from The Scripps Research Institute in 2003. Before moving to Gladstone/UCSF in early 2011, Ding was an Assistant Professor and then Associate Professor of Chemistry at Scripps from 2003 to 2011. Dr. Ding has pioneered on developing and applying innovative chemical approaches to stem cell biology and regeneration, with a focus on discovering and characterizing novel small molecules that can control various cell fate/function, including stem cell maintenance, activation, differentiation and reprogramming in various developmental stages and tissues. Ding has published over 100 research articles, reviews and book chapters, and made several seminal contributions to the stem cell field. Ding is a cofounder of Fate Therapeutics and Stemgent.